Endoscopic treatment of vesicoureteral reflux in pediatric patients
Endoscopic treatment is a minimally invasive treatment for managing patients with vesicoureteral reflux (VUR). Although several bulking agents have been used for endoscopic treatment, dextranomer/hyaluronic acid is the only bulking agent currently approved by the U.S. Food and Drug Administration fo...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Pediatric Society
2013-04-01
|
Series: | Korean Journal of Pediatrics |
Subjects: | |
Online Access: | http://kjp.or.kr/upload/pdf/kjped-56-145.pdf |
id |
doaj-0a897020b9be462d92275ea0f385463c |
---|---|
record_format |
Article |
spelling |
doaj-0a897020b9be462d92275ea0f385463c2020-11-24T23:14:28ZengKorean Pediatric SocietyKorean Journal of Pediatrics1738-10612092-72582013-04-0156414515010.3345/kjp.2013.56.4.1452012600091Endoscopic treatment of vesicoureteral reflux in pediatric patientsJong Wook Kim0Mi Mi Oh1Department of Urology, Korea University Guro Hospital, Seoul, Korea.Department of Urology, Korea University Guro Hospital, Seoul, Korea.Endoscopic treatment is a minimally invasive treatment for managing patients with vesicoureteral reflux (VUR). Although several bulking agents have been used for endoscopic treatment, dextranomer/hyaluronic acid is the only bulking agent currently approved by the U.S. Food and Drug Administration for treating VUR. Endoscopic treatment of VUR has gained great popularity owing to several obvious benefits, including short operative time, short hospital stay, minimal invasiveness, high efficacy, low complication rate, and reduced cost. Initially, the success rates of endoscopic treatment have been lower than that of open antireflux surgery. However, because injection techniques have been developed, a recent study showed higher success rates of endoscopic treatment than open surgery in the treatment of patients with intermediate- and high-grade VUR. Despite the controversy surrounding its effectiveness, endoscopic treatment is considered a valuable treatment option and viable alternative to long-term antibiotic prophylaxis.http://kjp.or.kr/upload/pdf/kjped-56-145.pdfVesico-ureteral refluxEndoscopy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jong Wook Kim Mi Mi Oh |
spellingShingle |
Jong Wook Kim Mi Mi Oh Endoscopic treatment of vesicoureteral reflux in pediatric patients Korean Journal of Pediatrics Vesico-ureteral reflux Endoscopy |
author_facet |
Jong Wook Kim Mi Mi Oh |
author_sort |
Jong Wook Kim |
title |
Endoscopic treatment of vesicoureteral reflux in pediatric patients |
title_short |
Endoscopic treatment of vesicoureteral reflux in pediatric patients |
title_full |
Endoscopic treatment of vesicoureteral reflux in pediatric patients |
title_fullStr |
Endoscopic treatment of vesicoureteral reflux in pediatric patients |
title_full_unstemmed |
Endoscopic treatment of vesicoureteral reflux in pediatric patients |
title_sort |
endoscopic treatment of vesicoureteral reflux in pediatric patients |
publisher |
Korean Pediatric Society |
series |
Korean Journal of Pediatrics |
issn |
1738-1061 2092-7258 |
publishDate |
2013-04-01 |
description |
Endoscopic treatment is a minimally invasive treatment for managing patients with vesicoureteral reflux (VUR). Although several bulking agents have been used for endoscopic treatment, dextranomer/hyaluronic acid is the only bulking agent currently approved by the U.S. Food and Drug Administration for treating VUR. Endoscopic treatment of VUR has gained great popularity owing to several obvious benefits, including short operative time, short hospital stay, minimal invasiveness, high efficacy, low complication rate, and reduced cost. Initially, the success rates of endoscopic treatment have been lower than that of open antireflux surgery. However, because injection techniques have been developed, a recent study showed higher success rates of endoscopic treatment than open surgery in the treatment of patients with intermediate- and high-grade VUR. Despite the controversy surrounding its effectiveness, endoscopic treatment is considered a valuable treatment option and viable alternative to long-term antibiotic prophylaxis. |
topic |
Vesico-ureteral reflux Endoscopy |
url |
http://kjp.or.kr/upload/pdf/kjped-56-145.pdf |
work_keys_str_mv |
AT jongwookkim endoscopictreatmentofvesicoureteralrefluxinpediatricpatients AT mimioh endoscopictreatmentofvesicoureteralrefluxinpediatricpatients |
_version_ |
1725594191758622720 |